(NYSE: BSX) Boston Scientific's forecast annual revenue growth rate of 9.08% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Boston Scientific's revenue in 2024 is $14,240,000,000.On average, 10 Wall Street analysts forecast BSX's revenue for 2024 to be $22,814,107,225,054, with the lowest BSX revenue forecast at $22,744,383,505,381, and the highest BSX revenue forecast at $22,872,020,824,930. On average, 10 Wall Street analysts forecast BSX's revenue for 2025 to be $24,867,360,370,483, with the lowest BSX revenue forecast at $24,526,087,519,922, and the highest BSX revenue forecast at $25,132,815,186,137.
In 2026, BSX is forecast to generate $27,178,301,527,317 in revenue, with the lowest revenue forecast at $26,823,569,541,473 and the highest revenue forecast at $27,691,429,959,625.